Cargando…
Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer
INTRODUCTION: There is a need for the development of new biomarkers for diagnosis and prognosis of ovarian cancer, which can ideally serve as targets for new therapeutic modalities and individualization of treatment. The objectives of this study were to determine the prognostic significance of the n...
Autores principales: | Santos, T.D., Jammal, M.P., Silveira, T.P., Murta, E.F.C., Nomelini, R.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186009/ https://www.ncbi.nlm.nih.gov/pubmed/31388197 http://dx.doi.org/10.32074/1591-951X-62-18 |
Ejemplares similares
-
Cytokines and Prognostic Factors in Epithelial Ovarian Cancer
por: Jammal, Millena Prata, et al.
Publicado: (2016) -
Immunostaining of stromal CD56 cells in ovarian malignancies
por: de Lima, Cid Almeida, et al.
Publicado: (2023) -
Is Ovarian Cancer Prevention Currently Still a recommendation of Our Grandparents?
por: Jammal, Millena Prata, et al.
Publicado: (2017) -
The Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Predicting Response to Platinum-based Chemotherapy for Epithelial Ovarian Cancer
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2021) -
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
por: Huang, Ke, et al.
Publicado: (2023)